Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Foolish J3 speculation
4
Sep 19, 2009 12:21PM

No matter what your perspective is as an investor with no PTSC management insight, you are definitely at a disadvantage in regard to the pending patent litigation. Something must still be pending with the J3; otherwise, Judge Ward would not still be overseeing the case. This action alone could be quite explosive for the stock once details are revealed. If any pending actions provide any significant compensation, the value of the patents will get a substantial power boost.


Sep 19, 2009 03:40PM
5
Sep 19, 2009 10:32PM
1
Sep 20, 2009 12:16AM
Share
New Message
Please login to post a reply